Table 1 Clinical and demographic characteristics of participants (N = 730)
Māori (N=241) | Non-Māoria (N=489) | Total (N=730) | ||
|---|---|---|---|---|
Characteristics | No. (%) | No. (%) | No. (%) | Any HPV positive (%) |
Histologically-confirmed CIN 2+ | 153 (63) | 287 (59) | 440 (60) | 423 (96) |
Cervical cancerb | 4 (2) | 8 (2) | 12 (2) | 11 (92) |
High grade lesion | 149 (62) | 269 (55) | 418 (57) | 404 (97) |
CIN 2c | 80 (33) | 149 (30) | 229 (31) | 224 (98) |
CIN 3 | 69 (29) | 120 (25) | 189 (26) | 180 (95) |
AIS or glandular dysplasia | 0 (0) | 10 (2) | 10 (1) | 8 (80) |
Histologically-confirmed < CIN 2 | 75 (31) | 186 (38) | 261 (36) | 232 (89) |
Low grade lesion | 43 (18) | 104 (21) | 147 (20) | 135 (92) |
CIN 1 | 20 (8) | 66 (13) | 86 (12) | 76 (88) |
Other low grade abnormalityd | 23 (10) | 38 (8) | 61 (8) | 59 (97) |
Negative | 32 (13) | 82 (17) | 114 (16) | 97 (85) |
Negative/normal | 19 (8) | 38 (8) | 57 (8) | 51 (89) |
Other non-significant abnormalitye | 13 (5) | 44 (9) | 57 (8) | 46 (81) |
No biopsy taken/reported | 13 (5) | 16 (3) | 29 (4) | 24 (83) |
Age 20–29 years | 121 (50) | 214 (44) | 335 (46) | 328 (98) |
Age 30–39 years | 77 (32) | 149 (30) | 226 (31) | 207 (92) |
Age 40–69 years | 43 (18) | 126 (26) | 169 (23) | 144 (85) |